share_log

Institutions Profited After Peijia Medical Limited's (HKG:9996) Market Cap Rose HK$484m Last Week but Individual Investors Profited the Most

Institutions Profited After Peijia Medical Limited's (HKG:9996) Market Cap Rose HK$484m Last Week but Individual Investors Profited the Most

機構受益於上週沛嘉醫療(臨時代碼)(HKG:9996)的市值上漲了48400萬港元,但個人投資者獲利最多
Simply Wall St ·  10/04 19:14

Key Insights

主要見解

  • Significant control over Peijia Medical by individual investors implies that the general public has more power to influence management and governance-related decisions
  • A total of 11 investors have a majority stake in the company with 51% ownership
  • Institutional ownership in Peijia Medical is 23%
  • 個體投資者對沛嘉醫療(臨時代碼)的重大控制意味着普通大衆有更多的權力來影響管理和治理決策
  • 共有11名投資者擁有該公司的大部分股權,佔有51%的所有權。
  • 沛嘉醫療(臨時代碼)的機構持股比例爲23%

A look at the shareholders of Peijia Medical Limited (HKG:9996) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are individual investors with 42% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

審視沛嘉醫療(臨時代碼)的股東可以告訴我們哪個群體最有權力。持有最大股份的群體是個體投資者,持股比例爲42%。換句話說,該群體面臨最大的上行潛力(或下行風險)。

Following a 22% increase in the stock price last week, individual investors profited the most, but institutions who own 23% stock also stood to gain from the increase.

上週股票價格上漲了22%,個人投資者獲利最多,但擁有23%股份的機構也從這次漲價中獲益。

Let's delve deeper into each type of owner of Peijia Medical, beginning with the chart below.

讓我們深入了解每種類型的沛嘉醫療所有者,從下面的圖表開始。

big
SEHK:9996 Ownership Breakdown October 4th 2024
SEHK:9996所有權分佈2024年10月4日

What Does The Institutional Ownership Tell Us About Peijia Medical?

機構所有權告訴我們關於沛嘉醫療的什麼?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構衡量其業績的標準是一個近似於當地市場的指數。因此,他們通常更加關注包括在主要指數中的公司。

We can see that Peijia Medical does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Peijia Medical's earnings history below. Of course, the future is what really matters.

我們可以看到沛嘉醫療確實有機構投資者;他們持有公司的相當比例的股票。這表明在專業投資者中有一定的信譽。但我們不能僅僅依賴這一事實,因爲機構有時也會做出糟糕的投資,就像每個人都會一樣。如果多家機構同時改變對一隻股票的看法,股價可能會迅速下跌。因此,值得看看下面的沛嘉醫療的收入歷史。當然,真正重要的是未來。

big
SEHK:9996 Earnings and Revenue Growth October 4th 2024
SEHK:9996 2024年10月4日盈利和營收增長

Hedge funds don't have many shares in Peijia Medical. The company's largest shareholder is XinYue International Limited, with ownership of 14%. Meanwhile, the second and third largest shareholders, hold 6.7% and 6.2%, of the shares outstanding, respectively. In addition, we found that Yi Zhang, the CEO has 0.8% of the shares allocated to their name.

對沛嘉醫療的對沖基金持有的股份不多。該公司最大的股東是XinYue International Limited,持有14%的股份。與此同時,第二和第三大股東分別持有流通股的6.7%和6.2%。此外,我們發現CEO張毅名下持有0.8%的股份。

Looking at the shareholder registry, we can see that 51% of the ownership is controlled by the top 11 shareholders, meaning that no single shareholder has a majority interest in the ownership.

查看股東註冊表,我們可以看到前11大股東控制着該公司51%的股權,這意味着沒有單一的股東擁有多數股權。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

儘管研究公司的機構持股可以增加您的研究價值,但研究分析師的建議也是一個好習慣,以更深入地了解股票的預期表現。有相當數量的分析師關注該股,因此了解他們對未來的總體觀點可能很有用。

Insider Ownership Of Peijia Medical

沛嘉醫療內部持股

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

公司內部人員的定義可能是主觀的,並且在不同的司法管轄區之間有所不同。我們的數據反映了個人內部人員,至少捕捉到董事會成員的記錄。公司管理人員向董事會報告,後者應該代表股東的利益。值得注意的是,有時高級管理人員自己也在董事會中。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認爲內部人士持股是一件好事。但是,在某些情況下,它會使其他股東更難以對董事會的決定進行問責。

Shareholders would probably be interested to learn that insiders own shares in Peijia Medical Limited. It has a market capitalization of just HK$2.7b, and insiders have HK$86m worth of shares, in their own names. This shows at least some alignment. You can click here to see if those insiders have been buying or selling.

股東可能會對沛嘉醫療(臨時代碼)的股權激勵感興趣。其市值僅爲27億港幣,內部人員持有8600萬港幣的股份,以自己的名義。這至少顯示了一定程度的一致性。您可以點擊這裏查看內部人員是否一直在買入或賣出。

General Public Ownership

一般大衆所有權

The general public, who are usually individual investors, hold a 42% stake in Peijia Medical. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

一般公衆,通常是個人投資者,持有沛嘉醫療(臨時代碼)42%的股份。雖然這種所有權規模可能不足以左右政策決定,但他們仍然可以對公司政策產生集體影響。

Private Equity Ownership

股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。

With an ownership of 13%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere.

公共公司目前擁有GeneDx Holdings股票的14%。我們不能確信,但這很可能是一種戰略持股。這些企業可能相似,或者彼此協作。

Private Company Ownership

私有公司的所有權

It seems that Private Companies own 19%, of the Peijia Medical stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

私營公司似乎擁有沛嘉醫療(臨時代碼)19%的股份。私營公司可能是相關方。有時內部人員通過持有私營公司的股權,而不是以個人名義持有公共公司股份,表現出對公共公司的利益。儘管很難得出任何廣泛的結論,但值得注意並作爲進一步研究的領域。

Next Steps:

下一步:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. To that end, you should be aware of the 1 warning sign we've spotted with Peijia Medical .

我發現查看公司的實際所有者非常有趣。但要真正獲得洞察,我們還需要考慮其他信息。爲此,您應該注意我們在沛嘉醫療(臨時代碼)發現的1個警示信號。

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

但最終,決定該業務所有者將獲得多大利益的是未來而非過去。因此,我們認爲最好查看此免費報告,以了解分析師是否預測更光明的未來。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論